Publication | Open Access

Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial

ThrombosisPreventive MedicineAt-risk OutpatientsLong CovidThromboprophylactic Low-molecular-weight HeparinInfection ControlMedicineAnticoagulantHeparinsCovid-19Phase 3B